In this study, we sought to investigate the consequences of an intestine-specific Usp22 deletion in mice undergoing acute dextran sodium sulfate (DSS)-induced colitis as well as inflammation-associated CRC. The gene discussed is USP22; the disease is colorectal carcinoma.